Table 3.
Patient | Sex | Age at initiation of HAART, years | HAART regimena | Duration of HAART, weeks | History of AIDS-related illness before HAART | Diagnosis/cause of death | Baseline CD4 cell percentage (CD4 cell count, cells/mL) | Baseline plasma HIV RNA level, log10 copies/mL |
---|---|---|---|---|---|---|---|---|
1 | M | 1.6 | NVP | 4 | None | Sepsis | 5 (90) | 5.83 |
2 | M | 4.7 | NVP | 4 | Penicillium marneffei infection | Mycobacterium avium complex infection | 0 (0) | ND |
3 | M | 10.9 | NVP | 5 | Disseminated Mycobacterium scrofulaceum infection | Pseudomonas aeruginosa pneumonia | 0 (0) | 4.86 |
4 | F | 7.6 | NVP | 6 | Bronchiectasis, P. marneffei infection | Pneumonia | 1 (ND) | ND |
5 | F | 9.7 | NVP | 6 | Mycobacterium kansasii infection | Staphylococcus aureus septicemia | 5 (65) | ND |
6 | M | 1.1 | EFV | 6 | Oral candidiasis, chronic diarrhea | Diarrhea/sepsis | 9 (314) | 4.80 |
7 | M | 3.3 | EFV | 7 | CMV retinitis, cryptococcal men ingitis, immune thrombocytopenic purpura, intracranial mass (presumptive tuberculoma) | IRS (postcraniotomy intracranial hemorrhage) | 1 (5) | 5.33 |
8 | M | 0.6 | NVP | 9 | CMV retinitis and colitis | IRS (CMV) presenting as myocarditis | 11 (740) | 5.88 |
9 | M | 13.6 | EFV | 12 | None | Sepsis | 1 (23) | 4.82 |
10 | M | 8.3 | EFV | 21 | P. marneffei infection, autoimmune hemolytic anemia and hepatitis | Salmonella septicemia | 0 (4) | 5.88 |
11 | F | 11.3 | EFV | 22 | CMV retinitis, HIV nephropathy, enteropathy, and encephalopathy | IRS (herpes simplex) presenting as encephalitis | 2 (12) | 5.09 |
12 | F | 8.7 | NVP | 26 | None | IRS (M. avium complex) | 6 (44) | 5.57 |
13 | M | 9.5 | NVP | 74 | M. avium complex infection | Chylous ascites with Escherichia coli septicemia | 0 (5) | 5.02 |
NOTE. CMV, cytomegalovirus; EFV, efavirenz; IRS, immune reconstitution syndrome; ND, not done; NVP, nevirapine.
”NVP” denotes a regimen of nevirapine, stavudine, and lamivudine; “EFV” denotes a regimen of efavirenz, stavudine, and lamivudine.